Академический Документы
Профессиональный Документы
Культура Документы
Biotechnology Advances
journal homepage: www.elsevier.com/locate/biotechadv
a r t i c l e
i n f o
Article history:
Received 13 June 2013
Received in revised form 4 November 2013
Accepted 17 November 2013
Available online xxxx
Keywords:
Microuidics
Lab on a chip
Immunology
Immunoassays
a b s t r a c t
Microuidics has facilitated immunological studies by enhancing speed, efciency and sensitivity of current analysis methods. It offers miniaturization of current laboratory equipment, and enables analysis of clinical samples
without the need for sophisticated infrastructure. More importantly, microuidics offers unique capabilities;
including conducting multiple serial or parallel tasks as well as providing complex and precisely controlled environmental conditions that are not achievable using conventional laboratory equipment. Microuidics is a promising technology for fundamental and applied immunological studies, allowing generation of high throughput,
robust and portable platforms, opening a new area of automation in immunology.
2013 Published by Elsevier Inc.
Contents
1.
2.
3.
4.
5.
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . .
The architecture of a future immuno lab-on-a-chip prototype system
On-chip manipulation of cells
. . . . . . . . . . . . . . . . . .
3.1.
Cell sorting and immobilization . . . . . . . . . . . . . .
3.1.1.
Mechanical lters . . . . . . . . . . . . . . . .
3.1.2.
Dielectrophoresis
. . . . . . . . . . . . . . . .
3.1.3.
Magnetophoresis
. . . . . . . . . . . . . . . .
3.1.4.
Acoustophoresis . . . . . . . . . . . . . . . . .
3.1.5.
Surface antigenantibody afnity . . . . . . . . .
3.1.6.
Fluorescent-activated cell sorting (FACS) . . . . . .
3.2.
Cell analysis . . . . . . . . . . . . . . . . . . . . . . .
3.2.1.
Cell migration . . . . . . . . . . . . . . . . . .
3.2.2.
Flow cytometry . . . . . . . . . . . . . . . . .
3.2.3.
Immunophenotyping . . . . . . . . . . . . . . .
3.2.4.
Single molecule analysis . . . . . . . . . . . . .
3.3.
Cell lysis . . . . . . . . . . . . . . . . . . . . . . . . .
On-chip manipulation of nucleic acids . . . . . . . . . . . . . . .
4.1.
Purication of nucleic acids . . . . . . . . . . . . . . . .
4.2.
Amplication of nucleic acids . . . . . . . . . . . . . . .
4.3.
Separation of nucleic acids . . . . . . . . . . . . . . . . .
On-chip manipulation of proteins . . . . . . . . . . . . . . . . .
5.1.
Detection of proteins . . . . . . . . . . . . . . . . . . .
5.2.
Purication of proteins . . . . . . . . . . . . . . . . . .
5.3.
Separation and analysis of proteins . . . . . . . . . . . . .
5.4.
Interfacing protein separation with mass spectrometry . . . .
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Correspondence to: S. Baratchi, School of Electrical and Computer Engineering, RMIT University, Melbourne, Australia.
Corresponding author.
E-mail addresses: sara.baratchi@rmit.edu.au (S. Baratchi), arnan.mitchell@rmit.edu.au (A. Mitchell).
0734-9750/$ see front matter 2013 Published by Elsevier Inc.
http://dx.doi.org/10.1016/j.biotechadv.2013.11.008
Please cite this article as: Baratchi S, et al, Immunology on chip: Promises and opportunities, Biotechnol Adv (2013), http://dx.doi.org/10.1016/
j.biotechadv.2013.11.008
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6.
Outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1. Introduction
Our knowledge of immunology has seen extraordinary advances
over the past three decades, driving the creation of new therapeutics
for human pathogenesis directed by the immune responses of our
bodies (Medzhitov et al., 2011). Our immune system has evolved as a
highly discriminatory defence mechanism to protect against potential
invaders. Cells in the immune system form a complex network with
other tissues and organs to defend our body. Immune cells are activated
in response to pathogens or indeed any abnormalities within the system
and begin sending signals to other cells. Many different signals have
been identied; including the expression of different cytokines or
protein markers, biochemical or mechanical interactions, cell-to-cell
contact, or cell migration, which determine the progress of immune or
inammatory responses (Male et al., 2012). To study and understand
such complex and subtle signalling mechanisms sophisticated and precise tools that can isolate each process at the microscale level are
required.
Microuidics, the science and technology of manipulating small
scale of uids (109 to 1018 l) within microscale structures, has enabled powerful platforms for fundamental and applied biomedical research (El-Ali et al., 2006). In particular, microuidics is a promising
technology for miniaturization and parallelization of immuno-assays,
while minimizing required sample volumes for precious and in some
cases unique specimens. These characteristics are especially valuable
for analysis of patient's samples with limited time, facilities and expertise. As such, microuidic systems are ideal platforms for monitoring
diseases in natural disaster affected areas or developing countries with
resource-limited settings (Sun and Morgan, 2010; Toner and Irimia,
2005; Yager et al., 2006).
The most important advantage of microuidic systems is their capability to process extremely low volumes of sample and reagents, which
signicantly reduces the cost of immunological assays and enables
studying small and/or rare cell populations from clinical patients.
More importantly, the ow remains laminar within the microuidic
systems, enabling the accurate control of ow variables such as velocity,
pressure and temperature. This facilitates the analysis of immune
responses under precisely controlled environmental conditions over
target cells (Abhyankar et al., 2006; El-Ali et al., 2006; Vickers et al.,
2012). Cells can be patterned in small clusters of a few or even single
cells to obtain deep and uncluttered insight into the heterogeneity of
the cell sample (Kim et al., 2009a). This enables studying the molecular
machinery of individual cells with a precision that cannot be matched
by conventional macroscopic counterparts (Sims and Allbritton, 2007).
Moreover, reducing the diffusion length leads to faster reaction
times in microuidic systems, enabling the dynamic analysis of immune
cell responses to different and highly controlled stimuli (Faley et al.,
2008). The increased surface-to-volume ratio of such systems also
makes possible the rapid and sensitive detection of cells, nucleic acids
or protein at very low concentrations that is essential early diagnosis
of diseases (He and Herr, 2010; Khoshmanesh et al., 2011c).
Several microuidic systems can be accommodated on a single chip
and connected in customized congurations so as to realize the desired
functionalities. They can be patterned either in parallel to increase the
ow throughput of a particular sample or to conduct the same experiment under an array of environmental conditions; (Munce et al.,
2004) or patterned in series to integrate multistep procedures such as
sorting, immobilization, lysis and chemical stimulation of cells (Easley
et al., 2006; Huang et al., 2006; Zare and Kim, 2010).
0
0
0
Please cite this article as: Baratchi S, et al, Immunology on chip: Promises and opportunities, Biotechnol Adv (2013), http://dx.doi.org/10.1016/
j.biotechadv.2013.11.008
Fig. 1. Layout of a fully integrated immuno lab-on-a-chip consisting of cell, nucleic acid and protein modules.
throughput sorting, these systems are expensive, and should be operated by expert personnel. Additionally the necessity of antibody labelling
makes them unsuitable for analysis of unknown populations of cells
for which well characterized marker antibodies are not available.
Centrifugation may also be used for separation of blood cells, based on
differential cellular density. Despite the simplicity of this method, one
important limitation is that it often requires relatively large blood sample volumes (millilitres). Additionally, for some cells, such as leukocytes,
that are sensitive to their environment, centrifugation might alter their
immunophenotypes (Gossett et al., 2010).
Microuidic platforms offer numerous advantages over conventional systems such as reduced sample volume, faster sample analysis,
high sensitivity, high temporal resolution, portability, and lower cost
(Microuidics for cell separation). The microuidic approaches can be
classied into passive/active groups according to the mode of actuation
Please cite this article as: Baratchi S, et al, Immunology on chip: Promises and opportunities, Biotechnol Adv (2013), http://dx.doi.org/10.1016/
j.biotechadv.2013.11.008
Table 1
A summary of techniques developed for cell sorting in microuidic platforms.
Mechanism
Description
Sorting criteria
Passive/active
Labelled/
label-free
Reference
Mechanical
Size, deformability
Passive
Label-free
Hydrodynamic
Size, shape
Passive
Label-free
Passive
Label-free
Active
Label-free
Active
Labelled
Active
Passive
Label-free
Labelled
Size, uorescence
Active
Labelled
Active
Label-free
Hemodynamic
Dielectrophoresis
Magnetophoresis
Acoustophoresis
Antibody/antigen afnity
Fluorescent activated
cell sorting
Optical
changing the frequency of the applied electric eld as well as the electrical conductivity of the medium.
Dielectrophoresis has been used for isolation of different cells based
on their cytoplasmic properties, including malaria-infected erythrocytes from blood (Gascoyne et al., 2002) and CTCs from blood samples
(Gascoyne et al., 2009). Live cells can thus be separated without
the need for labelling or modication, allowing each component to be
investigated further once sorting is complete.
Dielectrophoresis also enables the immobilization of live cells in intimate contact of each other to investigate the cellular response against
different chemical stimuli. For example, Khoshmanesh et al. investigated the cycloheximide-induced apoptosis of U937 human leukaemia
cells using an open-top dielectrophoretic platform (Khoshmanesh
et al., 2011b). The electro-thermal vortices generated within the
PDMS (polydimethylsiloxane) block enabled the rapid immobilization
of cells and efcient mixing of the specic drug with the buffer bathing
the cells (Fig. 2A). The patterned cells were later interfaced with ESEM
to analyse their morphological properties (Khoshmanesh et al., 2011a).
3.1.2. Dielectrophoresis
The induced motion of neutral particles under non-uniform electric
elds, can be used to isolate cells based on their dimensions or dielectric
properties (Pethig et al., 2010). The dielectrophoretic forces can direct
the cells towards the strong or weak electric eld regions. The nonuniform electric elds are generally created by integration of metallic
microelectrodes within microuidic platforms. However, it is possible
to generate non-uniform electric elds without the microelectrodes as
well (Shevkoplyas et al., 2005; Yang et al., 2006). Dielectrophoretic
systems are very exible as their performance can be ne-tuned by
3.1.3. Magnetophoresis
The induced motion of magnetic particles under magnetic elds has
been used for separating cells based on their dimensions or magnetic
susceptibility (Gossett et al., 2010). Magnetic elds can be readily
created by incorporation of permanent or electro-magnetic coils with
microuidic platforms (Gossett et al., 2010).
The target cells should be immune-magnetically labelled in order to
be manipulated by magnetophoresis. This is achieved by employing the
interaction of antibody-coated paramagnetic micro/nano particles
which interact with specic antigens on the surface of target cells.
Fig. 2. Microuidic platforms for sorting/immobilization of cells: (A) rapid immobilization and drug-induced death analysis of U937 human leukaemia cells using a ow-free
dielectrophoretic system, white arrows show the cell chains formed between opposite microelectrodes while red arrows show dying U937 cells stained with PI (Khoshmanesh et al.,
2011b), (B) size-based separation of platelets from white blood cells using a acoustophoretic system, (abbreviations: WBC: white blood cell, PLT: platelet), the inset shows the position
of cells with respect to acoustic waves (Dykes et al., 2011), (C) Isolation of rare circulating tumour cells from perpherial blood of cancer patients using a mechanical lter (Nagrath
et al., 2007) (For interpretation of the references to colour in this gure legend, the reader is referred to the web version of this article.)
Please cite this article as: Baratchi S, et al, Immunology on chip: Promises and opportunities, Biotechnol Adv (2013), http://dx.doi.org/10.1016/
j.biotechadv.2013.11.008
This method has been used to separate a variety of cells and particles,
among which are T-lymphocytes from whole blood (Kim et al.,
2009b), HIV virions from a mixture of blood cells (Chen et al., 2010b),
CD3+ T-lymphocytes from a mixture of cells (Kim et al., 2009b) and
CD34+ cells from fresh leukocytes (Jing et al., 2007). Magnetophoretic
separation based on nanoparticle uptake has also been employed to
separate macrophages from monocytes based on their endocytosis
capabilities (Robert et al., 2011). Furthermore, the intrinsic magnetic
properties of hemoglobins in erythrocytes have been exploited to achieve
the label-free separation of these cells. Specically, deoxygenated
haemoglobin is paramagnetic due to the presence of unpaired electrons,
while it becomes diamagnetic in its oxygenated form. It is this distinction
that allows the separation of red blood cells from leukocytes without
labelling them (Melville et al., 1975; Zborowski et al., 2003).
3.1.4. Acoustophoresis
The manipulation of dispersed particles by standing acoustic waves
is another separation method which has been used to separate cells
based on their size, density or compressibility (Lenshof and Laurell,
2011). This method relies on the creation of standing pressure waves
in a microchannel. These acoustic waves can be readily generated
through the use of microfabricated piezoelectric transducers within a
microuidic system (Lenshof and Laurell, 2011).
Acoustophoresis has been extensively applied to separate cells based
on their dimensions. One example is separation of plasma from the
whole blood, in which the blood cells are sequentially focused along
the channel centreline by an ultrasonic acoustic wave while the plasma
was withdrawn from the side outlets (Lenshof et al., 2009). The collected
plasma was later linked to an antibody microarray chip for prostate specic antigen detection. A similar concept has been adapted to separate
platelets from peripheral blood progenitor cells (Dykes et al., 2011)
(Fig. 2B). Another study enriched viable MCF-7 breast tumour cells
from a heterogeneous mixture of apoptotic cell, based on the fact that
the apoptotic cells are smaller than viable ones (Yang and Soh, 2012).
Acoustophoresis is currently at the state of transition to clinical laboratories and industries. It is relatively insensitive to media properties such as
pH and salt concentration, making it very compatible with a broad range
of biological assays (Lenshof and Laurell, 2011).
3.1.5. Surface antigenantibody afnity
Receptor targeting at the cell membrane is another approach for cell
separation that works by coating the microchannel surface with specic
antibodies to capture target cells (Grow et al., 2003; Ruan et al., 2002).
One example is a microchip consisting of an array of microposts functionalized with antibody (to anti-epithelial cell adhesion molecules) to
isolate CTSs in peripheral blood from patients with metastatic lung,
prostate, pancreatic, breast and colon cancers (Nagrath et al., 2007)
(Fig. 2C). Another example is the application of an antibody functionalized hydrogel for the isolation of CD34+ and Flk1+ cells (endothelial
progenitor cells) from untreated whole human blood by depleting
CD34+/Flk1 hematopoietic stem cells (Hatch et al., 2012). Alternatively, Vickers et al. developed a microuidic platform with antibodyconjugated surfaces to separate two phenotypically similar cells using
a single antibody (Vickers et al., 2012). The separation was based on variations of the binding afnity of cells as a function of shear stress, which
was modulated by changing the ow rate of the medium. The effectiveness of this method was demonstrated by separating two CD31+ cell
types: human umbilical vein endothelial cells; and human microvascular endothelial cells (Vickers et al., 2012). The capturing efciency of the
antibody-functionalized microchips can be enhanced by directing the
target cells towards the antibody coated regions via secondary forces
such as dielectrophoresis (Perroud et al., 2008). Moreover, the combination of antibodyantigen afnity with electrical impedance sensing has
been used to count the CD4+ T lymphocytes in a sample of leukocytes,
which offers a promising solution for on-chip quantitative diagnosis of
HIV (Davis et al., 2006).
Please cite this article as: Baratchi S, et al, Immunology on chip: Promises and opportunities, Biotechnol Adv (2013), http://dx.doi.org/10.1016/
j.biotechadv.2013.11.008
thus enabling the study of various readouts such as cell signalling under
dened chemical gradient conditions (Abhyankar et al., 2006). One
example is the application of a membrane-based system to generate a
chemical gradient across a microuidic channel for studying neutrophils
chemotaxis (Abhyankar et al., 2006). Another chip device has been
designed to apply a diffusion-driven gradient between two parallel channels connected via an array of straight and maze-like narrow channels to
analyse neutrophils chemotaxis (Ambravaneswaran et al., 2010).
3.2.1.2. Electrotaxis. It refers to cell migration directed by a physiologicallyrelevant direct current electric eld. The electric eld triggers cell signalling to guide cell movement, but not necessarily exerts a force on cells
(Li and Lin, 2011). Electrophoresis on the other hand can exert a force
on any charged particle and in the case of cells is associated with cell's
electrophoretic mobility. In conventional electrotaxis assays, the cell culture chamber is lled with electrolytes, and the electric eld is applied
across the chamber via agar salt bridges. Despite the simplicity of
this assay, the electric eld cannot be accurately controlled and the
throughput of the system is low (Li and Lin, 2011).
Microuidic platforms offer unique features for studying immune
cell electrotaxis as they enable the creation of uniform and controllable
electric elds within microuidic channels. Furthermore, real-time and
quantitative analysis of electrotaxis at a single cell level can be achieved.
For example, by imposing a controlled electric eld along a microuidic
channel, it has been shown that anti-CD3/CD28 activated lymphocytes
can migrate towards the cathode in the system (Li and Kolega, 2002).
It has been demonstrated that electrical stimulation can activate signalling pathways in T-lymphocytes similar to those induced by chemotaxis
stimulation, concomitantly causing the cells to migrate towards the
cathode (Lin et al., 2008).
Microuidic systems also have the potential to create simultaneously
both chemical gradients and electrical elds, to achieve deeper insight
into the migration of immune cells in electrochemical environments.
For example, studying the migration of T-cells under single and coexisting gradients of chemokine and electric eld indicated that the
combination of chemotaxis and electrotaxis can accelerate the migration
of T-cells towards the cathode (Li et al., 2012).
3.2.2. Flow cytometry
A variety of innovative ow cytometry (FCM) systems have been
reported for analysis of moving cells. One example is a FCM system
to measure relative concentrations of uorescently labelled subpopulations of lymphocytes and other leukocytes within blood samples
(Frankowski et al., 2011). The device utilized integrated optical bres
for laser excitation and detection of uorescent signals. In another
study, Skommer et al. pioneered the use of a FCM system to measure
cellular DNA content in both live and xed tumour cells, and also to
track the drug-induced activation of caspases and the dissipation of
mitochondrial inner membrane potential (m loss) with respect to
cell cycle stage of tumour cells (Skommer et al., 2013) (Fig. 3AB). Despite the essentially simple design, the system incorporated a dedicated
hardware interface comprising of a microcontroller-driven syringe
pump, spatially separated laser excitation sources, photodiodes, and
photomultiplier tubes to achieve an elegant separation. Further integration and miniaturization is certainly possible.
Alternatively, Holmes et al. (Holmes et al., 2009) developed a
microuidic impedance cytometer for the label-free differentiation of
leukocyte sub-populations (T-lymphocytes, neutrophils and monocytes). The microuidic chip took advantage of microelectrodes to measure the impedance of passing single cells at two frequencies of 503 and
1707 kHz. This enabled discrimination of leukocytes according to both
size and membrane capacitance.
3.2.3. Immunophenotyping
Phenotyping of immune cells through measurement of their functional status during different stages of the cell cycle is among the gold
Please cite this article as: Baratchi S, et al, Immunology on chip: Promises and opportunities, Biotechnol Adv (2013), http://dx.doi.org/10.1016/
j.biotechadv.2013.11.008
Fig. 3. Microuidic platforms for analysis/lysis of cells: (A) Analysis of programmed tumour cell death using a -ow cytometry chip. The chip was made of Poly(methyl methacrylate)
(PMMA), and comprised three modules: the input port with integrated cell sample and sheath uid reservoirs, a 75 m 50 m channel for 2D hydrodynamic focusing of cells, and
the output port with collection chambers (Skommer et al., 2013), (B) The optical hardware interface for (A) capable of four-colour detection using a combination of spatially separated
excitation 473 nm and 640 nm lasers, and photomultiplier tubes (PMTs) for uorescent signal collection in area, height and width parameters (Skommer et al., 2013), (C) Schematic
design of FCS2 Bioptechs chamber (Bioptechs, USA) used for studying immunological synapses, (D) T-cell receptor (TCR) clustering (red) and exclusion of CD45 molecule (green) from
microclusters. T-cells are injected into an imaging chamber containing supported planar bilayers and TCRs are visualized by TIRF. Figures show synapse formation between TCR and planar
bilayer containing major histocompatibility complex (MHC) and CD45 molecules at (iiii) 30 s and (ivvi) 30 min post contact formation (Varma et al., 2006). (E) Continuous chemical
lysis of EL-4 cells along a microuidic channel. Cells cross over from the carrier buffer to the lysis buffer as the carrier buffer is gradually washed via the bifurcation channels. The inset
shows a uorescent image of the dilution of the cell carrier buffer via the bifurcation channels (Mun et al., 2010).
Please cite this article as: Baratchi S, et al, Immunology on chip: Promises and opportunities, Biotechnol Adv (2013), http://dx.doi.org/10.1016/
j.biotechadv.2013.11.008
Fig. 4. Microuidic platforms for purication, amplication and separation of nucleic acids: (A) Dual-stage purication of DNA from whole blood, using a C18 silica bead column for
capturing proteins and a monolithic column for trapping DNA (Wen et al., 2007), (B) An integrated microchip for lysis of cells and viruses, followed by SPE extraction, PCR amplication,
labelling and immuno-chromatographic based detection of nucleic acids from the cell lysates. Reservoirs P1P6 contain lysis, inhibitor removal, wash, elution, and labelling buffers while
valves V1V4 control the ow between different components (Chen et al., 2010a), (C) Another fully integrated microchip designed for DNA-based screening for infectious pathogens from
the whole blood. Chip is composed of four modules for SPE extraction, PCR amplication, marker injection, and electrophoretic separation of DNA fragments; all connected via a network of
channels and elastomeric membrane valves (Easley et al., 2006).
Please cite this article as: Baratchi S, et al, Immunology on chip: Promises and opportunities, Biotechnol Adv (2013), http://dx.doi.org/10.1016/
j.biotechadv.2013.11.008
The extraction of RNA is more challenging than that of DNA due to its
susceptibility to degradation by Ribonucleases (RNases) (Rogacs et al.,
2012). To overcome this issue, Sattereld et al. developed a photopolymerized monolith for on-chip purication of eukaryotic mRNA
from total RNA (Sattereld et al., 2007). The monolith was functionalized with polythymine deoxyribonucleotides (oligo-dTs) which interact
with the poly-A tail of mRNA, thus capturing the nucleic acid. In another
study, Irimia demonstrated an integrated system for RNA isolation from
human monocyte cells (Irimia et al., 2009). Following cell lysis, appropriate agents were added to inactivate RNases and degrade cellular
proteins. The nucleic acids were subsequently captured on a silica
bead column while the contaminant DNA was removed by enzymatic
digestion before releasing the captured RNA. Other work has shown
the utilization of polymer capture matrices in the purication of
human immunodeciency virus (HIV) RNA from human sera (Root
et al., 2011). Serum was electrophoresed through the polymer matrix
in the chip, which had covalently bound oligonucleotides, thus selectively trapping target nucleic acids. The chip was then heated above
the melting temperature of the captured oligonucleotides to release
the target strands.
4.2. Amplication of nucleic acids
An important step in nucleic acid analysis is the amplication of captured nucleic acids using polymerase chain reaction (PCR). This method
relies on repeated heating and cooling of nucleic acid samples through
cycles of denaturation, annealing and extension of target sequences.
Conventional PCR thermocyclers consist of a thermal block with slot
arrays for PCR tubes. The temperature of the entire block must be
changed in order to achieve temperature changes in the samples. This
prolongs processing time, due to the large mass of the block. In addition,
one important challenge for the conventional PCR methods is the identication of small changes in gene expression that are usually associated
with different disease states. Quantitative PCR currently is the most sensitive approach that can identify 1.5-fold changes (Whale et al., 2012).
Microuidic PCR platforms dramatically reduce the amount of samples, reagents and analysis time, while increasing the precision of PCR
experiments (Baker, 2010). On-chip PCR has been demonstrated by
passing samples through serpentine channels, which are heated at
their bottom surface by means of patterned heaters (Crews et al.,
2008). The heaters create three isothermal zones along each channel,
enabling the cyclic denaturation, and extension of the target nucleic
acid sequence (Crews et al., 2008). Such continuous ow PCR systems
consume far less reagents and require shorter reaction times compared
to their conventional macroscopic counterparts (Zhang and Ozdemir,
2009). However, the large surface-to-volume ratio of such systems
leads to the adhesion of chemicals onto the surface of microuidic channels, which consequently leads to cross-contamination and inhibition of
PCR reactions (Zhang and Ozdemir, 2009). These issues can be overcome by utilizing droplet-based PCR systems, in which the PCR reaction
takes place in discrete droplets dispersed within an immiscible carrier
uid such as oil. The droplets can also be driven by electrowetting
mechanisms, where the wettability of the surface is modied via an
electric eld (Heyries et al., 2011; Hua et al., 2010). The rapid advances
in microfabrication technologies has enabled the creation of highly
integrated and fully automated PCR microuidic chips equipped with
micropumps, microvalves, and micromixers (Toetsch et al., 2009).
Integration of PCR microuidic components with pre- and post-PCR
processing units, as shown in Fig. 1, can further push the boundaries
of PCR-based diagnostic assays to make us one step closer to point-ofcare diagnosis of infectious diseases (Maecker et al., 2012).
4.3. Separation of nucleic acids
Gel electrophoresis is the traditional method of purifying nucleic
acid fragments, in which a DC electric eld is applied across an agarose
gel matrix to separate the samples based on their size. Despite the popularity of this technique, several manual steps are required including
staining and separation of nucleic acids followed by visualization and
quantication of separated bands, which elongate the process.
On-chip capillary electrophoresis (CE) has been demonstrated
by etching glass or quartz substrates to form capillaries. PDMS channels
are generally avoided for CE due to their permeability, which can cause
cross-contamination of nucleic acids. Integrated PCR-CE microuidic
systems capable of performing nucleic acid amplication and separation
have been demonstrated by several groups (Chen et al., 2010a; Easley
et al., 2006; Huang et al., 2006) (Fig. 4BC).
Isotachophoresis is another variant of electrophoresis, which has
been used for purication, stacking and separation of target nucleic
acids in microuidic systems. In isotachophoresis, the target sample is
introduced between the trailing and leading electrolytes whose electrophoretic mobilities are respectively lower and higher than that of the
sample. Upon application of an electric eld, the target samples are
concentrated between the trailing and leading electrolytes. This avoids
the dispersion and diffusion of the concentrated sample, and signicantly reduces the limit of detection, which cannot be achieved by CE
microdevices (Persat et al., 2009). Isotachophoresis has been used
extensively in microuidic systems, namely for the extraction and purication of genomic DNA from malaria infected red blood cells (Marshall
et al., 2011), extraction and enrichment of ribosomal RNA from whole
blood infected with bacteria (Rogacs et al., 2012), and detection of
microRNA using photo-polymerized functionalized hydrogels (GarciaSchwarz and Santiago, 2012).
5. On-chip manipulation of proteins
The density of intracellular proteins is much higher than that of DNA
or RNA. Despite this fact, measuring the expression level of the concentration of a protein of interest, especially in small cell samples is challenging due to the limitations of protein amplication. Heterogeneous
subsets of immune cells are present during immune responses to infection. These cells harbour both phenotypic and functional differences.
Thus, capturing a broad functional spectrum of given heterogeneous
cell populations remains challenging, and requires the analysis of a
large number of effector molecules from individual cells. In this regard,
microuidic platforms have been extensively utilized for the detection,
purication, separation and analysis of proteins, as summarized below.
5.1. Detection of proteins
Immunoassays using the high afnity of antigenantibody interactions have been widely used for protein detection. A variety of immunoassays are implemented in clinical laboratories. This includes ELISA to
detect and quantify the target antigen in a sample, immuno-blotting
to detect and approximate the size of a protein, ow cytometry to measure the expression of cell surface or intracellular proteins, and immunohistochemistry to detect and localize antigens in tissue samples. The
main disadvantage of these methods is that they are labour intensive
and time consuming. Additionally, they all rely on the availability of
commercial antibody conjugates to bind to target proteins and often
require 10 to 100 l of the sample (Hauss and Mller, 2007).
Microuidic platforms enable the transportation, mixing, separation
and detection of proteins in a 11000 picoliter range of sample volumes
(Freire and Wheeler, 2006). For example, a microuidic system was
developed to detect the cytokine tumour necrosis factor (TNF-)
(Cesaro-Tadic et al., 2004). In this work, a PDMS cover precoated with
capture antibodies was placed onto an array of parallel microchannels
to capture the moving analyte molecules. The PDMS cover was
then peeled off and orthogonally placed onto an array of parallel
microchannels where uorescently labelled detection antibodies were
moving. This led to the formation of a mosaic of uorescent signals
on the surface of PDMS. Moreover, researchers have succeeded in
Please cite this article as: Baratchi S, et al, Immunology on chip: Promises and opportunities, Biotechnol Adv (2013), http://dx.doi.org/10.1016/
j.biotechadv.2013.11.008
10
Fig. 5. Microuidic platforms for detection, purication and separation of proteins: (A) A fully integrated lab-on-a-disc ELISA system for detection of Hepatitis B virus antigen and antibody
from blood samples (Lee et al., 2009). The chip operation relies on spining of the disc to facilitate the transporation of liquid and laser controllable microvalves to control the ow. The
system enables the separation of plasma from the whole blood, incubation of plasma with antibody conjugated beads, several washing steps, mixing and reacting with TMB enzyme
substrates, and the absorbance detection at 450 and 630 nm within 30 min, (B) a serpentine PDMS column lled with an array of 50 m diameter pillars functionalized with covalently
bound antibodies for purication of recombinant afnity-tagged proteins from a bacterial lysate (Sandison et al., 2010), (C) the layout and operation of a microchip for automated immunoblotting of proteins realized by photopatterning of polyacrylamide gels on glass. The chip facilitates the rapid loading, stacking, PAGE separation, transfer and in gel blotting of proteins,
as indicated by blue and yellow bands. The direction of the electric current is shown by i (He and Herr, 2010) (For interpretation of the references to colour in this gure legend, the reader
is referred to the web version of this article.)
Please cite this article as: Baratchi S, et al, Immunology on chip: Promises and opportunities, Biotechnol Adv (2013), http://dx.doi.org/10.1016/
j.biotechadv.2013.11.008
11
Please cite this article as: Baratchi S, et al, Immunology on chip: Promises and opportunities, Biotechnol Adv (2013), http://dx.doi.org/10.1016/
j.biotechadv.2013.11.008
12
Fourth, most studies demonstrate only the proof-of-concept capability of microuidic platforms for conducting biological experiments
while there are only a few reported works in the literature, where
the utility of microuidic chips has been demonstrated in real clinical procedures. Among these is the microchip developed by Nagrath
et al. (2007) to capture CTCs in the peripheral blood of patients with
metastatic lung, prostate, pancreatic, breast and colon cancer in a
single step without any processing steps. Another example is the
microchip developed by Rosenbach et al. (2011) for rapid RNA extraction from highly pure T lymphocytes of burn-injured patients,
which was used for downstream evaluation of the gene expression
of cytokines via quantitative real-time PCR.
Fifth, to ensure that microuidic platforms can be routinely used in
clinical laboratories, they must be highly developed and free from
technical challenges that can present obstacles to users who are
not familiar with microuidic devices. Most devices are custom
designed for each application and thus may be prone to operational
issues such as leaking of microchannels, clogging of microchannels
by entrapped bubbles, and difculty in interfacing with several
inlet/outlet tubes. There exist several excellent technological solutions to these problems and it is suggested that standards be developed to ensure that all microuidic devices benet from these
solutions.
In conclusion, immuno lab-on-a-chip systems could be equipped
with several components to address (i) sample preparation, (ii) sorting,
immobilization, stimulation, and characterization of target cells,
(iii) lysing of target cells, (iv) capture, amplication, and separation of
target nucleic acids, (v) detection, capture, and separation of target
proteins, and (vi) interfacing target immobilized samples with offchip imaging or spectroscopy technologies. Such systems require the
design and implementation of modular microuidic components,
which can be easily laid in series to form highly integrated multipurpose immuno lab-on-a-chip platforms. These integrated systems
would enable the routine laboratory techniques to be performed with
smaller sample volumes, a smaller volume but larger array of consumables, and vastly reduced infrastructure scale and cost. A positive outlook is that in the future, more effective, robust, low-cost and portable
micro devices will be available for routine clinical procedures.
Acknowledgements
K. Khoshmanesh acknowledges the Australian Research Council
(project number DE120101402), D. Wlodkowic acknowledges the
Australian Research Council and RMIT Vice Chancellor's Senior Fellowship, P. McIntyre acknowledges the National Health and Medical Research
Council (project grant APP1046860) and A. Mitchell acknowledges the
Australian Research Council for funding.
References
Abhyankar VV, Lokuta MA, Huttenlocher A, Beebe DJ. Characterization of a membranebased gradient generator for use in cell-signaling studies. Lab Chip 2006;6:38993.
Ambravaneswaran V, Wong IY, Aranyosi AJ, Toner M, Irimia D. Directional decisions
during neutrophil chemotaxis inside bifurcating channels. Integr Biol 2010;2:63947.
Azimi SM, Nixon G, Ahern J, Balachandran W. A magnetic bead-based DNA extraction and
purication microuidic device. Microuid Nanouid 2011;11:15765.
Baker M. Clever PCR: more genotyping, smaller volumes. Nat Methods 2010;7:3515.
Baret J-C, Miller OJ, Taly V, Ryckelynck M, El-Harrak A, Frenz L, et al. Fluorescenceactivated droplet sorting (FADS): efcient microuidic cell sorting based on enzymatic activity. Lab Chip 2009;9:18508.
Brian AA, McConnell HM. Allogeneic stimulation of cytotoxic T cells by supported planar
membranes. Proc Natl Acad Sci U S A Biol Sci 1984;81:615963.
Cady NC, Stelick S, Batt CA. Nucleic acid purication using microfabricated silicon structures. Biosens Bioelectron 2003;19:5966.
Cesaro-Tadic S, Dernick G, Juncker D, Buurman G, Kropshofer H, Michel B, et al.
High-sensitivity miniaturized immunoassays for tumor necrosis factor a using
microuidic systems. Lab Chip 2004;4:5639.
Please cite this article as: Baratchi S, et al, Immunology on chip: Promises and opportunities, Biotechnol Adv (2013), http://dx.doi.org/10.1016/
j.biotechadv.2013.11.008
13
Olvecka E, Kaniansky D, Pollak B, Stanislawski B. Separation of proteins by zone electrophoresis on-line coupled with isotachophoresis on a column-coupling chip with
conductivity detection. Electrophoresis 2004;25:386574.
Peoples MC, Karnes HT. Microuidic capillary system for immunoafnity separations of
C-reactive protein in human serum and cerebrospinal uid. Anal Chem 2008;80:
38538.
Perroud TD, Kaiser JN, Sy JC, Lane TW, Branda CS, Singh AK, et al. Microuidic-based cell
sorting of Francisella tularensis infected macrophages using optical forces. Anal Chem
2008;80:636572.
Persat A, Marshall LA, Santiago JG. Purication of nucleic acids from whole blood using
isotachophoresis. Anal Chem 2009;81:950711.
Pethig R, Menachery A, Pells S, De Sousa P. Dielectrophoresis: a review of applications for
stem cell research. J Biomed Biotechnol 2010.
Quinto-Su PA, Lai H-H, Yoon HH, Sims CE, Allbritton NL, Venugopalan V. Examination
of laser microbeam cell lysis in a PDMS microuidic channel using time-resolved
imaging. Lab Chip 2008;8:40814.
Robert D, Pamme N, Conjeaud H, Gazeau F, Iles A, Wilhelm C. Cell sorting by endocytotic
capacity in a microuidic magnetophoresis device. Lab Chip 2011;11:190210.
Rogacs A, Qu Y, Santiago JG. Bacterial RNA extraction and purication from whole human
blood using isotachophoresis. Anal Chem 2012;84:585863.
Root BE, Agarwal AK, Kelso DM, Barron AE. Purication of HIV RNA from serum
using a polymer capture matrix in a microuidic device. Anal Chem 2011;83:
9828.
Rosenbach AE, Koria P, Goverman J, Kotz KT, Gupta A, Yu M, et al. Microuidics for
T-Lymphocyte cell separation and inammation monitoring in burn patients. Clin
Transl Sci 2011;4:638.
Rotman B. Measurement of activity of single molecules of beta-D-galactosidase. Proc Natl
Acad Sci U S A 1961;47:198191.
Ruan CM, Yang LJ, Li YB. Immunobiosensor chips for detection of Escherichia coli
O157: H7 using electrochemical impedance spectroscopy. Anal Chem 2002;74:
481420.
Sandison ME, Cumming SA, Kolch W, Pitt AR. On-chip immunoprecipitation for protein
purication. Lab Chip 2010;10:280513.
Sasuga Y, Iwasawa T, Terada K, Oe Y, Sorimachi H, Ohara O, et al. Single-cell chemical lysis
method for analyses of intracellular molecules using an array of picoliter-scale
microwells. Anal Chem 2008;80:91419.
Sattereld BC, Stern S, Caplan MR, Hukari KW, West JAA. Microuidic purication and
preconcentration of mRNA by ow-through polymeric monolith. Anal Chem
2007;79:62305.
Shevkoplyas SS, Yoshida T, Munn LL, Bitensky MW. Biomimetic autoseparation of leukocytes from whole blood in a microuidic device. Anal Chem 2005;77:9337.
Sims CE, Allbritton NL. Analysis of single mammalian cells on-chip. Lab Chip 2007;7:
42340.
Skommer J, Akagi J, Takeda K, Fujimura Y, Khoshmanesh K, Wlodkowic D. Multiparameter lab-on-a-chip ow cytometry of the cell cycle. Biosens Bioelectron 2013;42:
58691.
Sun T, Morgan H. Single-cell microuidic impedance cytometry: a review. Microuid
Nanouid 2010;8:42343.
Toetsch S, Olwell P, Prina-Mello A, Volkov Y. The evolution of chemotaxis assays
from static models to physiologically relevant platforms. Integr Biol 2009;1:
17081.
Toner M, Irimia D. Blood-on-a-chip. Annu Rev Biomed Eng 2005;7:77103.
Treanor B, Depoil D, Bruckbauer A, Batista FD. Dynamic cortical actin remodeling by ERM
proteins controls BCR microcluster organization and integrity. J Exp Med 2011;208:
105568.
Unger MA, Chou H-P, Thorsen T, Scherer A, Quake SR. Monolithic microfabricated valves
and pumps by multilayer soft lithography. Science 2000;288:1136.
VanDelinder V, Groisman A. Separation of plasma from whole human blood in a continuous cross-ow in a molded microuidic device. Anal Chem 2006;78:376571.
VanDelinder V, Groisman A. Perfusion in microuidic cross-ow: separation of white
blood cells from whole blood and exchange of medium in a continuous ow. Anal
Chem 2007;79:202330.
Varma R, Campi G, Yokosuka T, Saito T, Dustin ML. T cell receptor-proximal signals are
sustained in peripheral microclusters and terminated in the central supramolecular
activation cluster. Immunity 2006;25:11727.
Vickers DAL, Chory EJ, Murthy SK. Separation of two phenotypically similar cell types
via a single common marker in microuidic channels. Lab Chip 2012;12:
3399407.
Wen J, Guillo C, Ferrance JP, Landers JP. Microuidic-based DNA purication in a two-stage,
dual-phase microchip containing a reversed-phase and a photopolymerized monolith.
Anal Chem 2007;79:613542.
Wen J, Legendre LA, Bienvenue JM, Landers JP. Purication of nucleic acids in microuidic
devices. Anal Chem 2008;80:64729.
Whale AS, Huggett JF, Cowen S, Speirs V, Shaw J, Ellison S, et al. Comparison of
microuidic digital PCR and conventional quantitative PCR for measuring copy number variation. Nucleic Acids Res 2012:40.
Wlodkowic D, Telford W, Skommer J, Darzynkiewicz Z. Apoptosis and beyond: cytometry
in studies of programmed cell death. In: Darzynkiewicz Z, Holden E, Orfao A, Telford
W, Wlodkowic D, editors. Recent advances in cytometry, part b: advances in
applicationsFifth ed. 2011. p. 5598.
Wolfe KA, Breadmore MC, Ferrance JP, Power ME, Conroy JF, Norris PM, et al. Toward a
microchip-based solid-phase extraction method for isolation of nucleic acids. Electrophoresis 2002;23:72733.
Wolff A, Perch-Nielsen IR, Larsen UD, Friis P, Goranovic G, Poulsen CR, et al. Integrating
advanced functionality in a microfabricated high-throughput uorescent-activated
cell sorter. Lab Chip 2003;3:227.
Please cite this article as: Baratchi S, et al, Immunology on chip: Promises and opportunities, Biotechnol Adv (2013), http://dx.doi.org/10.1016/
j.biotechadv.2013.11.008
14
Zare RN, Kim S. Microuidic platforms for single-cell analysis. In: Yarmush ML, Duncan JS,
Gray ML, editors. Annual review of biomedical engineering, vol. 12. Palo Alto: Annual
Reviews 2010. p. 187201.
Zborowski M, Ostera GR, Moore LR, Milliron S, Chalmers JJ, Schechter AN. Red blood cell
magnetophoresis. Biophys J 2003;84:263845.
Zhang Y, Ozdemir P. Microuidic DNA amplication a review. Anal Chim Acta 2009;638:
11525.
Zheng S, Lin H, Liu J-Q, Balic M, Datar R, Cote RJ, et al. Membrane microlter device for
selective capture, electrolysis and genomic analysis of human circulating tumor
cells. J Chromatogr A 2007;1162:15461.
Please cite this article as: Baratchi S, et al, Immunology on chip: Promises and opportunities, Biotechnol Adv (2013), http://dx.doi.org/10.1016/
j.biotechadv.2013.11.008